Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    September 2018
  1. KUMAR R, Liu APY, Orr BA, Northcott PA, et al
    Advances in the classification of pediatric brain tumors through dna methylation profiling: from research tool to frontline diagnostic.
    Cancer. 2018 Sep 26. doi: 10.1002/cncr.31583.
    PubMed     Text format     Abstract available


    August 2018
  2. PRESS RH, Zhang C, Cassidy RJ, Ferris MJ, et al
    Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy.
    Cancer. 2018 Aug 18. doi: 10.1002/cncr.31589.
    PubMed     Text format     Abstract available


    June 2018
  3. KAMRAN SC, Goldberg SI, Kuhlthau KA, Lawell MP, et al
    Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31575.
    PubMed     Text format     Abstract available


    April 2018
  4. WICK W, Winkler F
    Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.
    Cancer. 2018 Apr 26. doi: 10.1002/cncr.31371.
    PubMed     Text format    


    March 2018
  5. ZUREICK AH, Evans CL, Niemierko A, Grieco JA, et al
    Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.
    Cancer. 2018 Mar 2. doi: 10.1002/cncr.31143.
    PubMed     Text format     Abstract available


    January 2018
  6. WELLER M
    Where does O(6) -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?
    Cancer. 2018 Jan 30. doi: 10.1002/cncr.31244.
    PubMed     Text format    


  7. SCHIFF D, Jaeckle KA, Anderson SK, Galanis E, et al
    Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
    Cancer. 2018 Jan 3. doi: 10.1002/cncr.31219.
    PubMed     Text format     Abstract available


  8. WANG N, Bertalan MS, Brastianos PK
    Leptomeningeal metastasis from systemic cancer: Review and update on management.
    Cancer. 2018;124:21-35.
    PubMed     Text format     Abstract available


    December 2017
  9. REARDON DA, Lassman AB, Schiff D, Yunus SA, et al
    Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
    Cancer. 2017 Dec 19. doi: 10.1002/cncr.31172.
    PubMed     Text format     Abstract available


  10. JHAVERI J, Liu Y, Chowdhary M, Buchwald ZS, et al
    Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31158.
    PubMed     Text format     Abstract available


    November 2017
  11. GEORGAKIS MK, Papathoma P, Ryzhov A, Zivkovic-Perisic S, et al
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Cancer. 2017;123:4458-4471.
    PubMed     Text format     Abstract available


  12. RYDZEWSKI NR, Lesniak MS, Chandler JP, Kalapurakal JA, et al
    Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31088.
    PubMed     Text format     Abstract available


    October 2017
  13. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


  14. SLOOT S, Chen YA, Zhao X, Weber JL, et al
    Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Cancer. 2017 Oct 12. doi: 10.1002/cncr.30946.
    PubMed     Text format     Abstract available


  15. MILLER JJ, Shih HA, Andronesi OC, Cahill DP, et al
    Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31039.
    PubMed     Text format     Abstract available


    September 2017
  16. HAN CH, Batchelor TT
    Diagnosis and management of primary central nervous system lymphoma.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30965.
    PubMed     Text format     Abstract available


  17. ARBOUR KC, Kris MG, Riely GJ, Ni A, et al
    Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30990.
    PubMed     Text format     Abstract available



  18. Wearable medical device improves survival for glioblastoma patients.
    Cancer. 2017;123:3433.
    PubMed     Text format    


  19. BENZ LS, Wrensch MR, Schildkraut JM, Bondy ML, et al
    Quality of life after surgery for intracranial meningioma.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30975.
    PubMed     Text format     Abstract available


  20. DIAO K, Sun Y, Yoo SK, Yu C, et al
    Safety-net versus private hospital setting for brain metastasis patients treated with radiosurgery alone: Disparities in follow-up care and outcomes.
    Cancer. 2017 Sep 13. doi: 10.1002/cncr.30984.
    PubMed     Text format     Abstract available


  21. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


    July 2017
  22. WAHL M, Chang SM, Phillips JJ, Molinaro AM, et al
    Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30909.
    PubMed     Text format     Abstract available


  23. FIELD KM, Phal PM, Fitt G, Goh C, et al
    The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30838.
    PubMed     Text format     Abstract available


  24. SATO M, Gunther JR, Mahajan A, Jo E, et al
    Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
    Cancer. 2017;123:2570-2578.
    PubMed     Text format     Abstract available


  25. ALVAREZ E, Keegan T, Johnston EE, Haile R, et al
    Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
    Cancer. 2017;123:2516-2523.
    PubMed     Text format     Abstract available


    June 2017
  26. WESTPHAL D, Glitza Oliva IC, Niessner H
    Molecular insights into melanoma brain metastases.
    Cancer. 2017;123.
    PubMed     Text format     Abstract available


  27. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


    May 2017
  28. LEHMANN V, Tuinman MA, Keim MC, Winning AM, et al
    Psychosexual development and satisfaction in long-term survivors of childhood cancer: Neurotoxic treatment intensity as a risk indicator.
    Cancer. 2017;123:1869-1876.
    PubMed     Text format     Abstract available


    April 2017
  29. AMSBAUGH MJ, Yusuf MB, Gaskins J, Burton EC, et al
    Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Database.
    Cancer. 2017 Apr 27. doi: 10.1002/cncr.30730.
    PubMed     Text format     Abstract available


  30. DEFILIPP Z, Li S, El-Jawahri A, Armand P, et al
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30695.
    PubMed     Text format     Abstract available


  31. KAWAMURA J, Kamoshida S, Shimakata T, Hayashi Y, et al
    Filter paper-assisted cell transfer (FaCT) technique: A novel cell-sampling technique for intraoperative diagnosis of central nervous system tumors.
    Cancer. 2017;125:277-282.
    PubMed     Text format     Abstract available


  32. YANEZ ML, Miller JJ, Batchelor TT
    Diagnosis and treatment of epidural metastases.
    Cancer. 2017;123:1106-1114.
    PubMed     Text format     Abstract available


    February 2017
  33. FISCHER-VALUCK BW, Chen I, Srivastava AJ, Floberg JM, et al
    Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
    Cancer. 2017;123:682-687.
    PubMed     Text format     Abstract available


  34. LANIER JC, Abrams AN
    Posterior fossa syndrome: Review of the behavioral and emotional aspects in pediatric cancer patients.
    Cancer. 2017;123:551-559.
    PubMed     Text format     Abstract available


  35. MILLER JA, Kotecha R, Ahluwalia MS, Mohammadi AM, et al
    Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Cancer. 2017 Feb 13. doi: 10.1002/cncr.30616.
    PubMed     Text format     Abstract available


  36. SANDLER KA, Shaverdian N, Cook RR, Kishan AU, et al
    Treatment trends for patients with brain metastases: Does practice reflect the data?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30607.
    PubMed     Text format     Abstract available


  37. ACQUAYE AA, Vera E, Gilbert MR, Armstrong TS, et al
    Clinical presentation and outcomes for adult ependymoma patients.
    Cancer. 2017;123:494-501.
    PubMed     Text format     Abstract available


    January 2017
  38. PRINTZ C
    Device rapidly measures cell growth and can help determine drug resistance in cancer.
    Cancer. 2017;123:10-11.
    PubMed     Text format    


    November 2016
  39. DUNN-PIRIO AM, Vlahovic G
    Immunotherapy approaches in the treatment of malignant brain tumors.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30371.
    PubMed     Text format     Abstract available


    October 2016
  40. BOELE FW, Given CW, Given BA, Donovan HS, et al
    Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30428.
    PubMed     Text format     Abstract available



  41. Erratum: Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R and Larocca LM. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer. 2011;117:162-17
    Cancer. 2016;122:3090.
    PubMed     Text format    


    September 2016
  42. CALDARELLA A, Barchielli A
    Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30341.
    PubMed     Text format    


  43. GRAMATZKI D, Weller M
    Reply to glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
    Cancer. 2016 Sep 13. doi: 10.1002/cncr.30340.
    PubMed     Text format    


    August 2016
  44. SHOUSHTARI AN, Munhoz RR, Kuk D, Ott PA, et al
    The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Cancer. 2016 Aug 17. doi: 10.1002/cncr.30259.
    PubMed     Text format     Abstract available


    June 2016
  45. DASENBROCK HH, Devine CA, Liu KX, Gormley WB, et al
    Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis.
    Cancer. 2016;122:1708-17.
    PubMed     Text format     Abstract available


    May 2016
  46. VERMA V, Mishra MV, Mehta MP
    A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
    Cancer. 2016;122:1483-501.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: